Product Not Found
The report you are looking for is no longer available. Here are some similar reports:
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
Published Apr 30, 2014 by GlobalData - $9995
Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies
Published May 12, 2014 by GBI Research - $3500
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
Published Jul 31, 2014 by GBI Research - $3500
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
Published Sep 30, 2014 by GBI Research - $4995
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2020 - Improved Regional Healthcare Access to Drive Uptake of High-Cost Targeted Therapies
Published Oct 31, 2014 by GBI Research - $4995
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
Published Sep 30, 2014 by GlobalData - $6995
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023
Published Sep 30, 2014 by GlobalData - $4995
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options
Published May 12, 2014 by GBI Research - $3500
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023
Published Sep 30, 2014 by GlobalData - $4995
PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022
Published Apr 30, 2014 by GlobalData - $10995